PSA vs PSTV · rev $1.23B vs P/E 0.2, rev $5.8M
PSA (PSA) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
PSA currently screens at market cap $0. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the PSA and PSTV stock pages for the full models.
Not investment advice.